Gao Ying, Zhou Yikun, Hong Zhidan, Ma Binyu, Wang Xiaojie, Nie Linhang, Ma Ling, Zhang Yuanzhen, Zhang Ming, Wang Mei
Center for Reproductive Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P.R. China.
Clinical Medicine Research Center of Prenatal Diagnosis and Birth Health in Hubei Province, Wuhan, Hubei, P.R. China.
Hum Reprod Update. 2025 Aug 22. doi: 10.1093/humupd/dmaf023.
RNA-binding proteins (RBPs) are indispensable for transcriptional and post-transcriptional processes during spermatogenesis, orchestrating germ cell proliferation, differentiation, and maturation. Despite their established importance, the contributions of RBPs in male infertility remain underexplored. Recently, a seminal Science publication reported an RBP atlas of 1744 murine testicular RBPs, 22 loss-of-function variants, and 137 deleterious missense variants identified in 1046 infertile patients, providing unprecedented opportunities to investigate their molecular and clinical relevance. Variants in RBP-related genes associated with azoospermia, oligozoospermia, teratozoospermia, and asthenozoospermia highlight their potential as diagnostic biomarkers and therapeutic targets. However, comprehensive analyses that integrate genetic, functional, and clinical insights are still lacking.
This review aims to systematically analyze the roles of RBPs in male infertility. Leveraging state-of-the-art datasets and experimental insights, it examines pathogenic variants and variants of uncertain significance (VUS), and elucidates the gene-disease relationships (GDRs). Furthermore, it explores known RBP functions across spermatogenesis stages and identifies candidate RBP genes. By integrating these findings, this work provides a comprehensive framework to advance the genetic understanding of RBPs, and their potential as clinical biomarkers and therapeutic targets in male infertility.
We searched the PubMed database for articles until 13 July 2025, using the keywords 'RNA-binding protein', 'male infertility', 'spermatogenesis', 'sperm', 'genetic variant', 'functional analyses', and 'knockout mouse model'. Pathogenic variants and VUS in 1744 RBP-coding genes, retrieved from the ClinVar and PubMed databases, were systematically analyzed to classify GDRs by the International Male Infertility Genomics Consortium database. Functional data from RBP knockout mouse models were assessed to elucidate stage-specific roles in spermatogenesis. Candidate RBP genes lacking knockout mouse models were identified by mining the RBP atlas, alongside data from the Genotype-Tissue Expression, Human Protein Atlas, and Uniprot databases. The clinical potential of RBPs as diagnostic biomarkers and therapeutic targets was also discussed.
Our search generated ∼2000 records, and 331 relevant articles were ultimately included in the final text. Firstly, this review identified 177 pathogenic variants in 62 RBP genes and 91 VUS in 35 RBP genes, 15 of which have been confidently linked to human male infertility. Secondly, functional analyses of 124 RBP knockout mouse models revealed their stage-specific regulatory roles in spermatocytogenesis, spermatidogenesis, and spermiogenesis, offering insights into key processes such as piwi-interacting RNA biogenesis, chromatin remodeling, and RNA stability. Thirdly, 38 RBP genes lacking knockout mouse models were screened as candidate RBP genes in male infertility, underscoring their potential for future functional investigations. Finally, this review discusses the clinical potential of RBPs as biomarkers and therapeutic targets, including RNA-based drugs, small molecules, and gene editing technologies as innovative strategies to address RBP-related male infertility.
This review highlights the role of RBPs in male infertility and offers a framework for integrating genetic, functional, and clinical data. By identifying candidate RBPs and their therapeutic potential, it lays the groundwork for future diagnostic advancements and personalized treatments in reproductive medicine.
N/A.
RNA结合蛋白(RBPs)在精子发生过程中的转录和转录后过程中不可或缺,协调生殖细胞的增殖、分化和成熟。尽管它们的重要性已得到确立,但RBPs在男性不育中的作用仍未得到充分探索。最近,《科学》杂志发表的一篇开创性文章报道了1744种小鼠睾丸RBPs的图谱、22种功能丧失变体以及在1046名不育患者中鉴定出的137种有害错义变体,为研究它们的分子和临床相关性提供了前所未有的机会。与无精子症、少精子症、畸形精子症和弱精子症相关的RBP相关基因变体突出了它们作为诊断生物标志物和治疗靶点的潜力。然而,仍缺乏整合遗传、功能和临床见解的全面分析。
本综述旨在系统分析RBPs在男性不育中的作用。利用最新的数据集和实验见解,研究致病变体和意义未明的变体(VUS),并阐明基因-疾病关系(GDRs)。此外,探讨已知的RBPs在精子发生各阶段的功能,并确定候选RBP基因。通过整合这些发现,本研究提供了一个全面的框架,以推进对RBPs的遗传学理解,以及它们作为男性不育临床生物标志物和治疗靶点的潜力。
我们在PubMed数据库中搜索截至2025年7月13日的文章,使用关键词“RNA结合蛋白”、“男性不育”、“精子发生”、“精子”、“基因变体”、“功能分析”和“基因敲除小鼠模型”。从ClinVar和PubMed数据库中检索到的1744个RBP编码基因中的致病变体和VUS,由国际男性不育基因组学联盟数据库进行系统分析,以分类GDRs。评估RBP基因敲除小鼠模型的功能数据,以阐明其在精子发生中的阶段特异性作用。通过挖掘RBP图谱以及来自基因型-组织表达、人类蛋白质图谱和通用蛋白质数据库的数据,确定缺乏基因敲除小鼠模型的候选RBP基因。还讨论了RBPs作为诊断生物标志物和治疗靶点的临床潜力。
我们的检索产生了约2000条记录,最终331篇相关文章被纳入正文。首先,本综述在62个RBP基因中鉴定出177个致病变体,在35个RBP基因中鉴定出91个VUS,其中15个已被确定与人类男性不育有关。其次,对124个RBP基因敲除小鼠模型的功能分析揭示了它们在精母细胞发生、精子细胞发生和精子形成中的阶段特异性调节作用,为诸如与Piwi相互作用的RNA生物合成、染色质重塑和RNA稳定性等关键过程提供了见解。第三,筛选出38个缺乏基因敲除小鼠模型的RBP基因作为男性不育的候选RBP基因,强调了它们未来进行功能研究的潜力。最后,本综述讨论了RBPs作为生物标志物和治疗靶点的临床潜力,包括基于RNA的药物、小分子和基因编辑技术,作为解决与RBP相关的男性不育的创新策略。
本综述强调了RBPs在男性不育中的作用,并提供了一个整合遗传、功能和临床数据的框架。通过确定候选RBPs及其治疗潜力,为生殖医学未来的诊断进展和个性化治疗奠定了基础。
无。